Key result
Integrating biopsy, autoantibodies, and advanced imaging facilitates personalized management of myocarditis.
Why the study?
Myocarditis represents a challenging diagnosis with variable clinical presentation, unpredictable course, and lack of established causative treatment, despite increasing incidence and expanding non-invasive diagnostic methods.
This review provides updated diagnostic and therapeutic algorithms for the personalized management of myocarditis and inflammatory cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Should not yet change myocarditis practice; leaves open prospective validation of personalized biopsy and imaging strategies.
Tymińska et al. (2022) conducted a review in Myocarditis and Inflammatory Cardiomyopathy. Personalized management (endomyocardial biopsy, anti-heart autoantibodies, non-invasive imaging) was evaluated. Personalized management incorporating endomyocardial biopsy, anti-heart autoantibodies, and advanced non-invasive imaging facilitates comprehensive individualized treatment of myocarditis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: